Vildagliptin is an orally active pharmaceutical ingredient used as a DPP-4 inhibitor for the management of type 2 diabetes mellitus. Vildagliptin or VILDAGLIPTIN [EMA EPAR] functions by increasing incretin levels, which regulate glucose homeostasis through enhanced insulin secretion and suppressed glucagon release. Vildagliptin has suitability for formulation development, clinical research, and pilot-scale API production. Also referred to as (LAF237, Vildagliptin Hydrochloride) by Vildagliptin manufacturers, characterised by high potency, oral bioavailability, and metabolic stability. We are the trusted Vildagliptin supplier worldwide, ensuring reliable lead times and consistent quality for pharmaceutical manufacturing and research.
Vildagliptin is an orally active pharmaceutical ingredient used as a DPP-4 inhibitor for the management of type 2 diabetes mellitus. Vildagliptin or VILDAGLIPTIN [EMA EPAR] functions by increasing incretin levels, which regulate glucose homeostasis through enhanced insulin secretion and suppressed glucagon release. Vildagliptin has suitability for formulation development, clinical research, and pilot-scale API production. Also referred to as (LAF237, Vildagliptin Hydrochloride) by Vildagliptin manufacturers, characterised by high potency, oral bioavailability, and metabolic stability. We are the trusted Vildagliptin supplier worldwide, ensuring reliable lead times and consistent quality for pharmaceutical manufacturing and research.
.3d8f8f41.svg)
Pharmaceutical
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Active Pharmaceutical Ingredients (APIs)
.7767eb0f.png&w=3840&q=75){kind=small}
Chemical Properties & Specifications
H413 (90.1%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]
P273, and P501
Treatment of type 2 diabetes mellitus.
DPP-4 inhibition increases incretin levels, enhancing insulin secretion.
High oral absorption allows flexible dosing.
Resistant to rapid metabolism, enabling consistent therapeutic effects.
Preferred in preclinical and clinical research on DPP-4 inhibitors and glucose metabolism studies.
Store at 15–25°C (59–77°F)
Protect from moisture and light; keep in tightly sealed containers